{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:19:22Z","timestamp":1790403562317,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brain Korea (BK21) PLUS program"},{"DOI":"10.13039\/501100011017","name":"Recherches Scientifiques Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006672","name":"Action Lions Vaincre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006672","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BK21 PLUS, South Korea"},{"name":"BK21"},{"name":"T\u00e9l\u00e9vie"},{"name":"T\u00e9l\u00e9vie"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MEST of Korea for Tumor Microenvironment Global Core Research Center","award":["NRF-2011-0030001"],"award-info":[{"award-number":["NRF-2011-0030001"]}]},{"name":"Seoul National University Research Grant"},{"DOI":"10.13039\/501100002551","name":"Seoul National University (SNU)","doi-asserted-by":"crossref","award":["370C-20160062"],"award-info":[{"award-number":["370C-20160062"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BK21"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.canlet.2018.07.041","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T23:20:48Z","timestamp":1536448848000},"page":"197-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release"],"prefix":"10.1016","volume":"438","author":[{"given":"Aloran","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oualid","family":"Talhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Chateauvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthoula","family":"Gaigneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Ry","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Dicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Bachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur M.S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Orlikova-Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canlet.2018.07.041_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.canlet.2018.07.041_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","article-title":"BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia","volume":"26","author":"Zabriskie","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2018.07.041_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Perl","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.canlet.2018.07.041_bib4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cell.2015.11.031","article-title":"A new golden age of natural products drug discovery","volume":"163","author":"Shen","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2018.07.041_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biotechadv.2014.03.006","article-title":"From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment","volume":"32","author":"Cerella","year":"2014","journal-title":"Biotechnol. Adv."},{"issue":"328","key":"10.1016\/j.canlet.2018.07.041_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aae0105","article-title":"Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma","volume":"8","author":"Garg","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2018.07.041_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","article-title":"Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy","volume":"153","author":"Radogna","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2018.07.041_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2013.05.001","article-title":"Crosstalk between ER stress and immunogenic cell death","volume":"24","author":"Kepp","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.canlet.2018.07.041_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1078\/0171-9335-00377","article-title":"Dicumarol, an inhibitor of ADP-ribosylation of CtBP3\/BARS, fragments golgi non-compact tubular zones and inhibits intra-golgi transport","volume":"83","author":"Mironov","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.canlet.2018.07.041_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mc.22094","article-title":"A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death","volume":"54","author":"Bana","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"11","key":"10.1016\/j.canlet.2018.07.041_bib11","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.bmc.2014.03.046","article-title":"Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-kappaB regulation","volume":"22","author":"Talhi","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.canlet.2018.07.041_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2017.12.007","article-title":"Cytostatic hydroxycoumarin OT52 induces ER\/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer","volume":"416","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.07.041_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmech.2014.07.003","article-title":"Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells","volume":"84","author":"Orlikova","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"136","key":"10.1016\/j.canlet.2018.07.041_bib14","doi-asserted-by":"crossref","DOI":"10.3791\/57490","article-title":"Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts","author":"Lee","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.canlet.2018.07.041_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2alpha phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2018.07.041_bib16","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.4410.2","article-title":"CyKEGGParser: tailoring kegg pathways to fit into systems biology analysis workflows","volume":"3","author":"Nersisyan","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.canlet.2018.07.041_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.fct.2013.06.051","article-title":"Styryl-lactone goniothalamin inhibits TNF-alpha-induced NF-kappaB activation","volume":"59","author":"Orlikova","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"1\u20133","key":"10.1016\/j.canlet.2018.07.041_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2018.07.041_bib19","first-page":"63","article-title":"Role of oxidative stress in modulating unfolded protein response activity in chronic myeloid leukemia cell line","volume":"20","author":"Bazi","year":"2016","journal-title":"Iran. Biomed. J."},{"issue":"9","key":"10.1016\/j.canlet.2018.07.041_bib20","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.cellsig.2013.05.019","article-title":"Chibby drives beta catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells","volume":"25","author":"Mancini","year":"2013","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.canlet.2018.07.041_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12185-011-0918-4","article-title":"Activation of the unfolded protein response in primary acute myeloid leukemia cells","volume":"94","author":"Tanimura","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2018.07.041_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.fitote.2015.03.010","article-title":"DAW22, a natural sesquiterpene coumarin isolated from Ferula ferulaeoides (Steud.) Korov. that induces C6 glioma cell apoptosis and endoplasmic reticulum (ER) stress","volume":"103","author":"Zhang","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.canlet.2018.07.041_bib23","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","article-title":"ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells","volume":"8","author":"Lecciso","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2018.07.041_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2018.07.041_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2018.07.041_bib26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/cdd.2008.67","article-title":"The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death","volume":"15","author":"Panaretakis","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2018.07.041_bib27","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1038\/cddis.2013.207","article-title":"Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation","volume":"4","author":"Kono","year":"2013","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.canlet.2018.07.041_bib28","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1002\/anie.201500934","article-title":"Induction of immunogenic cell death by chemotherapeutic platinum complexes","volume":"54","author":"Wong","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.canlet.2018.07.041_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/0008-5472.CAN-10-2788","article-title":"Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis","volume":"71","author":"Schiavoni","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2018.07.041_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/jkst.20006","article-title":"STAT signaling in the pathogenesis and treatment of myeloid malignancies","volume":"1","author":"Bar-Natan","year":"2012","journal-title":"JAK-STAT"},{"issue":"3","key":"10.1016\/j.canlet.2018.07.041_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy","volume":"99","author":"Bibi","year":"2014","journal-title":"Haematologica"},{"issue":"7569","key":"10.1016\/j.canlet.2018.07.041_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature15248","article-title":"Erosion of the chronic myeloid leukaemia stem cell pool by PPARgamma agonists","volume":"525","author":"Prost","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2018.07.041_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","article-title":"Targeting NF-kappaB in hematologic malignancies","volume":"13","author":"Braun","year":"2006","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.canlet.2018.07.041_bib34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.55","article-title":"Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem\/progenitor cells","volume":"25","author":"Allan","year":"2011","journal-title":"Leukemia"},{"issue":"355","key":"10.1016\/j.canlet.2018.07.041_bib35","doi-asserted-by":"crossref","first-page":"355ra117","DOI":"10.1126\/scitranslmed.aag1180","article-title":"Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells","volume":"8","author":"Carter","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2018.07.041_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejps.2016.11.021","article-title":"Clementine juice has the potential for drug interactions - in vitro comparison with grapefruit and Mandarin juice","volume":"97","author":"Theile","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2018.07.041_bib37","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","article-title":"BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors","volume":"111","author":"Copland","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.canlet.2018.07.041_bib38","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2008-06-164582","article-title":"Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD\/SCID repopulating cells","volume":"115","author":"Heaney","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2018.07.041_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"Zhang","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.canlet.2018.07.041_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Invest."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518305524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518305524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:44:27Z","timestamp":1589942667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518305524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"alternative-id":["S0304383518305524"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.07.041","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}